| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
12-04-2012, 02:42 PM
|
#1 | |||
|
||||
|
Member
|
Antibodies developed by researchers at Rensselaer Polytechnic Institute are unusually effective at preventing the formation of toxic protein particles linked to Alzheimer's disease and Parkinson's disease, as well as Type 2 diabetes, according to a new study...
Read more at: http://medicalxpress.com/news/2012-1...sease.html#jCp More information: Results of the new study, titled "Rational design of potent domain antibody inhibitors of amyloid fibril assembly," were published online last week by the journal Proceedings of the National Academy of Sciences (PNAS). The study may be viewed at: http://www.pnas.org/content/109/49/1...6-d5d57920c868
__________________
Sim00 Born in 1969, diagnosed PD in 2007, first symptoms 2004. DBS in July 2016. |
|||
|
 Reply With Quote
|
| "Thanks for this!" says: | olsen (12-04-2012) |
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Antibodies May Slow Alzheimer?s | Alzheimer's Disease | |||
| First diagnostic test for Alzheimer's and Parkinson's disease on the horizon | Parkinson's Disease | |||
| Highly Promising Dutch Research Into Alzheimer's Disease and Parkinson's Disease | Parkinson's Disease | |||
Novel antibodies for combating Alzheimer's and Parkinson's disease
Linear Mode
